Johnson & Johnson (NYSE: JNJ)

Federman & Sherwood Announces Jury Verdict Against Johnson & Johnson

Oklahoma City, OK (February 29, 2016) – The law firm of Federman & Sherwood, with offices in Oklahoma City & Dallas, announces that a bellwether trial resulted in a multi-million dollar verdict against Johnson & Johnson (NYSE:  JNJ). 

If you know of or are someone who had used Johnson & Johnson talc-based powder and have had or now have ovarian cancer, please contact Robin Hester at rkh@federmanlaw.com or call (405) 235-1560, for more information.  

 


Copyright © 2017 Federman & Sherwood. All Rights Reserved.